Cell Therapy Manufacturing and Gene Therapy Congress

A session at Cell Therapy Manufacturing and Gene Therapy Congress

-Network and partner with 200+ cell and gene therapy manufacturers, regulators, quality and analytical scientists, all facing the same challenges as you

-Quiz key European regulators on the various regulatory pathways available to innovators and the common quality/CMC pitfalls encountered

- Hear how Chiesi took the first stem cell to market - CMC and post-approval considerations

- Big pharma have truly arrived - GSK, Pfizer and Biogen reveal their manufacturing strategies for cell and gene-based therapies - how do they differ from yours?

- Quiz Miltenyi, Merck, Cook and CellGenix on the quality of your starting materials and accountability if things go wrong

-New, bigger venue with conferences and exhibition on one floor

Download the brochure for more information:

Booking: http://atnd.it/30747-0
Inquiries: http://atnd.it/30747-1

Conference only: GBP 1499
Conference + Evening Seminar: GBP 1998
Conference + Workshop: GBP 2199
Conference +1 workshop + 1 Evening Seminar: GBP 2598

Speakers: GSK, Juno Therapeutics, bluebird, Celyad, Uniqure, EATRIS

Sign in to add slides, notes or videos to this session

Tell your friends!


Date Wed 2nd December 2015

Short URL


Official event site


View the schedule


See something wrong?

Report an issue with this session